MAPK7 and diffuse intrinsic pontine glioma: Interestingly, ERK5 has recently been identified as a key factor in promoting cell growth and cell survival in the aggressive diffuse intrinsic pontine gliomas [190], supporting recent evidence around ERK5 as an emerging novel oncology drug target [191, 192, 193].